104 related articles for article (PubMed ID: 2554766)
1. A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma.
Cloud ML; Enas GC; Kemp J; Platts-Mills T; Altman LC; Townley R; Tinkelman D; King T; Middleton E; Sheffer AL
Am Rev Respir Dis; 1989 Nov; 140(5):1336-9. PubMed ID: 2554766
[TBL] [Abstract][Full Text] [Related]
2. Effect of a leukotriene antagonist, LY171883, on cold air-induced bronchoconstriction in asthmatics.
Israel E; Juniper EF; Callaghan JT; Mathur PN; Morris MM; Dowell AR; Enas GG; Hargreave FE; Drazen JM
Am Rev Respir Dis; 1989 Nov; 140(5):1348-53. PubMed ID: 2817597
[TBL] [Abstract][Full Text] [Related]
3. Primate myocardial and systemic hemodynamic responses to leukotriene D4: antagonism by LY171883.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1987 Jul; 242(1):62-9. PubMed ID: 3612538
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
[TBL] [Abstract][Full Text] [Related]
5. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
Dahlén B; Margolskee DJ; Zetterström O; Dahlén SE
Thorax; 1993 Dec; 48(12):1205-10. PubMed ID: 8303624
[TBL] [Abstract][Full Text] [Related]
6. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
Phillips GD; Rafferty P; Robinson C; Holgate ST
J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene (LT) receptor antagonists. Heterocycle-linked tetrazoles and carboxylic acids. LY203647.
Marshall WS; Sigmund SK; Whitesitt CA; Lifer SL; Roman CR; Rinkema LE; Hahn RA; Fleisch JH
Agents Actions; 1989 Jun; 27(3-4):309-12. PubMed ID: 2552762
[TBL] [Abstract][Full Text] [Related]
9. Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects.
Fuller RW; Black PN; Dollery CT
J Allergy Clin Immunol; 1989 May; 83(5):939-44. PubMed ID: 2715552
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
11. The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep.
Abraham WM; Wanner A; Stevenson JS; Chapman GA
Prostaglandins; 1986 Mar; 31(3):457-67. PubMed ID: 3754973
[TBL] [Abstract][Full Text] [Related]
12. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
13. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
14. Long-term metaproterenol therapy in asthmatic children.
Brandon ML
JAMA; 1976 Feb; 235(7):736-7. PubMed ID: 765528
[TBL] [Abstract][Full Text] [Related]
15. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Wahedna I; Wisniewski AS; Tattersfield AE
Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE
J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587
[TBL] [Abstract][Full Text] [Related]
18. Reversal of leukotriene D4- and leukotriene E4-induced airway constriction in the guinea pig.
Silbaugh SA; Stengel PW; Pechous PA; Marshall WS
Am Rev Respir Dis; 1989 Sep; 140(3):610-4. PubMed ID: 2571321
[TBL] [Abstract][Full Text] [Related]
19. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
20. Effect of RG 12525, a new leukotriene antagonist, on pulmonary function of asthmatic adults.
Welch MJ; Nelson HS; Paull BR; Smith JA; Feiss G; Tobey RE
Ann Allergy; 1994 Apr; 72(4):348-52. PubMed ID: 8154635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
